vs
Healthpeak Properties（DOC）与STEPAN CO（SCL）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是STEPAN CO的1.2倍（$719.4M vs $604.5M），Healthpeak Properties净利率更高（73.2% vs 3.3%，领先69.9%），Healthpeak Properties同比增速更快（3.1% vs 1.9%），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs 4.2%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
斯特潘公司是一家美国特种化学品制造商，总部位于伊利诺伊州诺斯布鲁克，1932年由小阿尔弗雷德·C·斯特潘创立，现有约2000名员工，目前由创始人的孙子小F·奎因·斯特潘执掌。该公司是全球最大的阴离子表面活性剂商品生产商，产品用于提升洗涤剂、洗发水、牙膏及化妆品的起泡与清洁能力。
DOC vs SCL — 直观对比
营收规模更大
DOC
是对方的1.2倍
$604.5M
营收增速更快
DOC
高出1.2%
1.9%
净利率更高
DOC
高出69.9%
3.3%
两年增速更快
DOC
近两年复合增速
4.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $604.5M |
| 净利润 | $114.0M | $19.7M |
| 毛利率 | — | 10.7% |
| 营业利润率 | 17.4% | 4.7% |
| 净利率 | 73.2% | 3.3% |
| 营收同比 | 3.1% | 1.9% |
| 净利润同比 | 2406.4% | — |
| 每股收益（稀释后） | $0.16 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCSCL
| Q1 26 | — | $604.5M | ||
| Q4 25 | $719.4M | $553.9M | ||
| Q3 25 | $705.9M | $590.3M | ||
| Q2 25 | $694.3M | $594.7M | ||
| Q1 25 | $702.9M | $593.3M | ||
| Q4 24 | $698.0M | $525.6M | ||
| Q3 24 | $700.4M | $546.8M | ||
| Q2 24 | $695.5M | $556.4M |
净利润DOCSCL
| Q1 26 | — | $19.7M | ||
| Q4 25 | $114.0M | $5.0M | ||
| Q3 25 | $-117.1M | $10.8M | ||
| Q2 25 | $31.7M | $11.3M | ||
| Q1 25 | $42.8M | $19.7M | ||
| Q4 24 | $4.5M | $3.4M | ||
| Q3 24 | $85.9M | $23.6M | ||
| Q2 24 | $146.0M | $9.5M |
毛利率DOCSCL
| Q1 26 | — | 10.7% | ||
| Q4 25 | — | 9.3% | ||
| Q3 25 | 58.6% | 12.0% | ||
| Q2 25 | 60.2% | 12.1% | ||
| Q1 25 | 61.1% | 12.7% | ||
| Q4 24 | 60.3% | 10.8% | ||
| Q3 24 | 60.0% | 13.8% | ||
| Q2 24 | 60.6% | 12.5% |
营业利润率DOCSCL
| Q1 26 | — | 4.7% | ||
| Q4 25 | 17.4% | 1.9% | ||
| Q3 25 | 9.2% | 3.7% | ||
| Q2 25 | 5.7% | 3.0% | ||
| Q1 25 | 7.7% | 4.8% | ||
| Q4 24 | -2.2% | 1.5% | ||
| Q3 24 | 14.1% | 4.4% | ||
| Q2 24 | 22.3% | 3.4% |
净利率DOCSCL
| Q1 26 | — | 3.3% | ||
| Q4 25 | 73.2% | 0.9% | ||
| Q3 25 | -16.6% | 1.8% | ||
| Q2 25 | 4.6% | 1.9% | ||
| Q1 25 | 6.1% | 3.3% | ||
| Q4 24 | 0.7% | 0.6% | ||
| Q3 24 | 12.3% | 4.3% | ||
| Q2 24 | 21.0% | 1.7% |
每股收益（稀释后）DOCSCL
| Q1 26 | — | $0.86 | ||
| Q4 25 | $0.16 | $0.22 | ||
| Q3 25 | $-0.17 | $0.47 | ||
| Q2 25 | $0.05 | $0.50 | ||
| Q1 25 | $0.06 | $0.86 | ||
| Q4 24 | $0.02 | $0.14 | ||
| Q3 24 | $0.12 | $1.03 | ||
| Q2 24 | $0.21 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | — |
| 总债务越低越好 | $9.8B | $328.4M |
| 股东权益账面价值 | $7.5B | $1.2B |
| 总资产 | $20.3B | $2.3B |
| 负债/权益比越低杠杆越低 | 1.31× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资DOCSCL
| Q1 26 | — | — | ||
| Q4 25 | $467.5M | $132.7M | ||
| Q3 25 | $91.0M | $118.5M | ||
| Q2 25 | $89.4M | $88.9M | ||
| Q1 25 | $70.6M | $107.5M | ||
| Q4 24 | $119.8M | $99.7M | ||
| Q3 24 | $180.4M | $147.3M | ||
| Q2 24 | $106.9M | $124.7M |
总债务DOCSCL
| Q1 26 | — | $328.4M | ||
| Q4 25 | $9.8B | $626.7M | ||
| Q3 25 | $9.1B | $655.5M | ||
| Q2 25 | $9.0B | $658.0M | ||
| Q1 25 | $8.9B | $659.3M | ||
| Q4 24 | $8.7B | $625.4M | ||
| Q3 24 | $8.6B | $688.5M | ||
| Q2 24 | $8.6B | $657.1M |
股东权益DOCSCL
| Q1 26 | — | $1.2B | ||
| Q4 25 | $7.5B | $1.2B | ||
| Q3 25 | $7.6B | $1.2B | ||
| Q2 25 | $7.9B | $1.2B | ||
| Q1 25 | $8.2B | $1.2B | ||
| Q4 24 | $8.4B | $1.2B | ||
| Q3 24 | $8.6B | $1.2B | ||
| Q2 24 | $8.8B | $1.2B |
总资产DOCSCL
| Q1 26 | — | $2.3B | ||
| Q4 25 | $20.3B | $2.4B | ||
| Q3 25 | $19.6B | $2.4B | ||
| Q2 25 | $19.8B | $2.4B | ||
| Q1 25 | $19.8B | $2.4B | ||
| Q4 24 | $19.9B | $2.3B | ||
| Q3 24 | $20.0B | $2.4B | ||
| Q2 24 | $20.2B | $2.3B |
负债/权益比DOCSCL
| Q1 26 | — | 0.28× | ||
| Q4 25 | 1.31× | 0.50× | ||
| Q3 25 | 1.20× | 0.53× | ||
| Q2 25 | 1.14× | 0.53× | ||
| Q1 25 | 1.08× | 0.55× | ||
| Q4 24 | 1.04× | 0.53× | ||
| Q3 24 | 1.00× | 0.56× | ||
| Q2 24 | 0.98× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | — |
| 自由现金流经营现金流 - 资本支出 | $357.0M | — |
| 自由现金流率自由现金流/营收 | 49.6% | — |
| 资本支出强度资本支出/营收 | 124.4% | — |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCSCL
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $60.0M | ||
| Q3 25 | $315.0M | $69.8M | ||
| Q2 25 | $363.5M | $11.2M | ||
| Q1 25 | $279.4M | $6.9M | ||
| Q4 24 | $1.1B | $68.3M | ||
| Q3 24 | $318.2M | $22.7M | ||
| Q2 24 | $316.2M | $29.5M |
自由现金流DOCSCL
| Q1 26 | — | — | ||
| Q4 25 | $357.0M | $25.4M | ||
| Q3 25 | — | $40.2M | ||
| Q2 25 | — | $-14.4M | ||
| Q1 25 | — | $-25.8M | ||
| Q4 24 | $333.7M | $32.1M | ||
| Q3 24 | — | $-4.0M | ||
| Q2 24 | — | $-208.0K |
自由现金流率DOCSCL
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | 4.6% | ||
| Q3 25 | — | 6.8% | ||
| Q2 25 | — | -2.4% | ||
| Q1 25 | — | -4.3% | ||
| Q4 24 | 47.8% | 6.1% | ||
| Q3 24 | — | -0.7% | ||
| Q2 24 | — | -0.0% |
资本支出强度DOCSCL
| Q1 26 | — | — | ||
| Q4 25 | 124.4% | 6.3% | ||
| Q3 25 | — | 5.0% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 5.5% | ||
| Q4 24 | 105.6% | 6.9% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | 5.3% |
现金转化率DOCSCL
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | 11.99× | ||
| Q3 25 | — | 6.44× | ||
| Q2 25 | 11.48× | 0.99× | ||
| Q1 25 | 6.52× | 0.35× | ||
| Q4 24 | 235.43× | 20.38× | ||
| Q3 24 | 3.71× | 0.96× | ||
| Q2 24 | 2.17× | 3.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
SCL
| Surfactants | $453.7M | 75% |
| Polymers | $130.0M | 22% |
| Specialty Products | $20.8M | 3% |
